What question did this study set out to answer?

To summarize current mechanistic insights into canonical and non-canonical NF-κB pathway regulation and evaluate therapeutic opportunities for targeting these pathways in inflammatory diseases and cancer.

September 21, 2020Signal Transduction and Targeted TherapyOpen Access

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

View Full Paper

Ask AI

Bookmark

Authors

HYHui YuSichuan University LLLiangbin LinChengdu Third People's Hospital ZZZhiqiang ZhangDalian Medical University

Discussion

Member takes

Implication

Review details molecular regulation of canonical and non-canonical NF-κB pathways, highlighting therapeutic targeting in inflammatory disorders and cancer.

Key Points

To summarize current mechanistic insights into canonical and non-canonical NF-κB pathway regulation and evaluate therapeutic opportunities for targeting these pathways in inflammatory diseases and cancer.
Review of mechanistic and preclinical literature assessing signal transduction kinetics, ubiquitination-dependent regulatory control, and pathological dysregulation of NF-κB signaling complexes.
Canonical NF-κB signaling induces rapid, transient transcription of proinflammatory genes in response to diverse stimuli, whereas non-canonical signaling mediated by select TNF receptor superfamily members displays slow, persistent kinetics critical for immune cell and lymphoid organ development.
Ubiquitination serves as an essential regulatory checkpoint for controlling activation thresholds in both canonical and non-canonical pathways.
Aberrant, persistent NF-κB activation directly drives chronic inflammatory pathologies and oncogenesis, establishing pathway-selective inhibition as a compelling therapeutic strategy.

Cite This Study

Yu et al. (2020) studied this question.

synapsesocial.com/papers/69d6166df653e43faa88b3b9 https://doi.org/10.1038/s41392-020-00312-6

View Full Paper

Ask AI

Bookmark

Implication

Review details molecular regulation of canonical and non-canonical NF-κB pathways, highlighting therapeutic targeting in inflammatory disorders and cancer.

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

Discussion

Member takes

Implication

Key Points

Cite This Study

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider